The safety of rosuvastatin: effects on renal and hepatic function

Author： Guthrie Robert M   Martin Daniel R  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.6, Iss.5, 2007-09, pp. : 573-581

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Hepatic or Renal Impairment on the Pharmacokinetics of Aripiprazole

By Mallikaarjun Suresh  

Clinical Pharmacokinetics, Vol. 47, Iss. 8, 2008-01 ,pp. : 533-542

Adis International

Access to resources Recommend Favorite

Postmarketing study supports rosuvastatin safety

By  

Reactions Weekly, Vol. 1, Iss. 1140, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Rosuvastatin: efficacy, safety and clinical effectiveness

By Soran Handrean   Durrington Paul  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2145-2160

Informa Healthcare

Access to resources Recommend Favorite

Effects of Rosuvastatin versus Atorvastatin on Rho-associated Coiled-coil Containing Protein Kinase Activity and Endothelial Function in Patients with Atherosclerosis

By Liu B   Cao HM   Li GY   Liu M   Feng J   Li J   Wang Q  

The Journal of International Medical Research, Vol. 39, Iss. 6, 2011-11 ,pp. : 2314-2322

Field House Publishing

Access to resources Recommend Favorite

Differential effects of sulindac on renal hemodynamics and function in the rat

By Kramp R.A.   Caron N.   Genard J.   Lejeune C.   Gulbis E.   Herman A.  

European Journal of Pharmacology, Vol. 330, Iss. 2, 1997-07 ,pp. : 165-176

Elsevier

Access to resources Recommend Favorite